Compare KPTI & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KPTI | INTT |
|---|---|---|
| Founded | 2008 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 175.3M |
| IPO Year | 2013 | 1997 |
| Metric | KPTI | INTT |
|---|---|---|
| Price | $5.38 | $15.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $17.50 | $13.50 |
| AVG Volume (30 Days) | ★ 659.3K | 145.8K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | $66,801,000.00 |
| Revenue This Year | N/A | $13.07 |
| Revenue Next Year | $46.62 | $6.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.57 | ★ 66.06 |
| 52 Week Low | $3.51 | $5.24 |
| 52 Week High | $10.99 | $15.01 |
| Indicator | KPTI | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 26.90 | 75.85 |
| Support Level | $3.95 | $7.21 |
| Resistance Level | $6.96 | N/A |
| Average True Range (ATR) | 0.88 | 0.92 |
| MACD | -0.36 | -0.02 |
| Stochastic Oscillator | 5.83 | 93.27 |
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.